Eupantol and cytolytic hepatitis Patient Reports February 10, 2010
Eupantol Side Effects Report #5404274-X
Eupantol side effect was reported by a Health Professional from FRANCE on July 27, 2007. Female patient, 45 years of age, was diagnosed with oesophagitis, angina pectoris, hypothyroidism, diabetes mellitus, hyperlipidaemia and was treated with Eupantol. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic steatosis, hepatomegaly, serum ferritin increased. Eupantol dosage: unknown. During the same period patient was treated with DILTIAZEM, LEVOTHYROXINE, KARDEGIC, ACARBOSE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Eupantol Side Effects Report #5458651-1
Eupantol side effect was reported by a Health Professional from FRANCE on Sept 11, 2007. Female patient, 44 years of age, was diagnosed with arthritis
, arthropathy, essential hypertension and was treated with Eupantol. After drug was administered, patient experienced the following side effects: angioedema, cytolytic hepatitis, eosinophilia, hepatitis cholestatic, hypotension. Eupantol dosage: unknown. During the same period patient was treated with TOPALGIC, COAPROVEL, INDOCIN. Patient was hospitalized. Patient recovered.Eupantol Side Effects Report #4743942-X
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on July 29, 2005. Female patient, 81 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: coagulation factor v level decreased, cytolytic hepatitis, haemoglobin decreased, hepatic artery thrombosis, hepatic failure, hyperammonaemia, lactic acidosis, platelet count decreased, prothrombin level decreased. Eupantol dosage: 40 MG 1X PER 1 DAY. During the same period patient was treated with CANCIDAS, SYNERCID, TARGOCID. Patient died.
Eupantol Side Effects Report #4765850-0
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on Aug 24, 2005. Female patient, 81 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, haemoglobin decreased, hepatic artery thrombosis, hepatic failure, hyperammonaemia, lactic acidosis, platelet count decreased, renal failure. Eupantol dosage: 40 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CANCIDAS, SYNERCID, TARGOCID. Patient was hospitalized. Patient died.
Eupantol Side Effects Report #5237319-0
Eupantol side effect was reported by a Health Professional from FRANCE on Feb 01, 2007. Female patient, 70 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, thrombocytopenia. Eupantol dosage: unknown. Patient was hospitalized. Patient recovered.
Eupantol Side Effects Report #4856312-0
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on Dec 12, 2005. Male patient, 64 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic steatosis. Eupantol dosage: 20 MG 1X PER 1 DAY ORAL. During the same period patient was treated with NEXEN, MODURETIC, LEVOTHYROXINE, PIRIBEDIL. Patient was hospitalized. Patient recovered.
Eupantol and cytolytic hepatitis 